COOKEVILLE, Tenn.–(BUSINESS WIRE)–Aphena Pharma Solutions Inc. today announced that it has approved $7
million for company-wide expansion for future growth opportunities to be
completed by the end of 2019. Targeted expansion areas include
additional manufacturing space, custom blending suites, new liquid
blending vessels and an additional high-speed bottling line.
“As Aphena continues our path towards healthcare contract service
excellence and innovation, we are committed to investing in our
customers’ future and earning our place as their preferred and trusted
partner,” said Aphena CEO Shawn Reilley.
The $7 million expansion includes:
Two additional large pharmaceutical blending suites with separate air
handling systems in the company’s manufacturing facility in Maryland
Two “state of the art” tri-mix blending tanks with counter-rotating
sweep and high-shear mixing with vacuum to handle small and large
batching for specialty creams, gels and topical products
- A 30,000-square-foot expansion of the Tennessee facility
An additional high-speed, fully-automated bottling line with
serialization in the company’s Tennessee facility to support both
over-the-counter (OTC) and prescription products
“These planned expansions at our Maryland and Tennessee facilities will
position Aphena to support significant future growth,” said Aphena COO
Bob Scott. “We are committed to investing aggressively as needed to
ensure that Aphena remains an industry leader in terms of innovation and
Aphena Pharma Solutions Inc. is an industry-leading organization
providing contract packaging and manufacturing solutions for the
pharmaceutical, consumer health and medical device markets. With two
separate FDA- and DEA-registered sites in the U.S., Aphena handles solid
dose, liquids, gels, creams, ointments, foams, suspensions and lotions.
For more information about Aphena, visit www.AphenaPharma.com
or call 1-866-465-4506.
Aphena Pharma Solutions Inc.
Eric Allen, 1-866-465-4506